Last updated on June 2019

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis


Brief description of study

B7451013 is a Phase 3 study to evaluate PF-04965842 in patients aged 12 years and older with a minimum body weight of 40 kg who have moderate to severe atopic dermatitis. The efficacy and safety of two dosage strengths of PF-04965842, 100 mg and 200 mg taken orally once daily, will be evaluated relative to placebo over 12 weeks of study participation. Eligible patients will have an option to enter a long-term extension study after completing 12 weeks of treatment.

Clinical Study Identifier: NCT03575871

Find a site near you

Start Over

Peninsula Research Associates, Inc.

Rolling Hills Estates, CA United States
  Connect »

Clinical Science Institute

Santa Monica, CA United States
  Connect »

Asthma and Allergy Associates, PC

Colorado Springs, CO United States
  Connect »

Colorado Springs Dermatology Clinic, PC

Colorado Springs, CO United States
  Connect »

Olympian Clinical Research

Clearwater, FL United States
  Connect »

Precision Imaging

Jacksonville, FL United States
  Connect »

Imaging Center of Idaho

Caldwell, ID United States
  Connect »

ASR, LLC

Nampa, ID United States
  Connect »

Meridian Clinical Research

Baton Rouge, LA United States
  Connect »

MediSearch Clinical Trials

Saint Joseph, MO United States
  Connect »

Sadick Research Group, LLC

New York, NY United States
  Connect »

PMG Research of Wilmington, LLC

Wilmington, NC United States
  Connect »

Diagnostic MRI

Houston, TX United States
  Connect »

The Skin Centre

Benowa, Australia
  Connect »

Sinclair Dermatology

East Melbourne, Australia
  Connect »

Winnipeg Clinic

Winnipeg, MB Canada
  Connect »

York Dermatology Center

Richmond Hill, ON Canada
  Connect »

Research Toronto

Toronto, ON Canada
  Connect »

ISA GmbH

Berlin, Germany
  Connect »

Inha University Hospital

Jung-gu, Korea, Republic of
  Connect »

University of Miami

Miami, FL United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.